Joint statement: Call for increased political commitment and accountability in preparation for the 2023 UN High-Level Meeting on TB

WHO Director-General and WHO Civil Society Task Force on TB release a joint statement setting collective priorities in preparation for the 2023 UN High-Level Meeting on TB.

Read More →

1 / 4 / 6 x 24 Campaign launched to rally energy, political will, funding needed to fight TB

At the International AIDS Conference in Montreal, civil society and activist organizations launched a new campaign inspired by the legacy of the late Dr. Paul Farmer calling for the “staff, stuff, space, systems, and support” necessary for shorter, effective TB treatment regimens to reach all who need them as a human right by the end of 2024.

Read More →

Partners announce reduced price for patient-friendly TB preventive treatments

Partners announce two new agreements to lower the price of rifapentine-based treatments to prevent TB in low- and middle-income countries.

Read More →

TB CAB 10-year anniversary evaluation report 2011–2021 and podcast

In 2021, TB CAB celebrated its tenth anniversary of advocating for community engagement in research and improved access to TB prevention, treatment, and diagnostic technologies.

Read More →

Urgent call for better use of existing vaccines and development of new vaccines to tackle AMR

The World Health Organization releases the first-ever report on the pipeline of the vaccines currently in development to prevent infections caused by antimicrobial-resistant bacterial pathogens.

Read More →

WHO announces updates on its guidance on TB care and support

The World Health Organization releases updated guidelines and a new operational handbook on TB care and support to improve the quality of life and better outcomes for people with TB.

Read More →

Global Plan to End TB 2023-2030 launched

The Global Plan to End TB 2023-2030 outlines the priority actions and estimated financial resources needed to end TB as a global health threat by 2030.

Read More →

Activists across the world demand urgent action to improve access to lifesaving TB medicine, bedaquiline

Communities affected by TB everywhere have a right to benefit from scientific progress, including access to short-course, bedaquiline-based treatment regimens for drug-resistant TB.

Read More →

Analysis: People-centered, rights-based TB legislation in Eastern Europe and Central Asia

The Global TB Caucus releases an analysis examining the region’s laws on public health, health systems, labor, TB, and other infectious diseases.

Read More →

Major improvements in quality of life for people with drug-susceptible TB expected following updates in TB treatment regimens

The updated WHO consolidated guidelines on treatment of drug-susceptible TB include a new recommendation for the use of a 4-month regimen composed of isoniazid, rifapentine, moxifloxacin and pyrazinamid.

Read More →

Page 1 of 116 · Total posts: 10

1 2 Last→

To subscribe to the Weekly Newsletter of new posts, enter your email here:

Learn About TB